The Mass Spectrometry lab was established in accordance with clinical mass spectrometry laboratory quality system standards ISO15189 and CLSI-62A. The lab provides services of assay development, assay commercialization, and scientific research. We have independently developed several hundreds of laboratory tests and established mass spectrometry analysis methods for various chronic diseases and cancers, which can analyze analytes of proteins, peptides, amino acids, bile acids, fatty acids, carbohydrates, etc. This platform provides reliable technical support for personalized screening of diseases, precise diagnostics, selection of treatment plan, and evaluation of prognosis. Jusbio Sciences (Shanghai) Co., Ltd., a subsidiary of Dunwill Medical, with a complete assay commercialization platform, supports the transfer and manufacturing of in vitro diagnostics assays. We work together to provide customers high-quality IVD products, and professional technical and scientific supports.
Clinical Mass Spectrometry Total Solution
.svg)
Driven by clinical applications, focusing on clinical needs, deeply integrating industrial, academia and scientific research, and achieving collaborative innovation!
We provide turnkey solutions of assay development, validation, and commercialization according to customer needs.
Product
Advanced technologies, profound accumulation, customized solutions for comprehensively analyzing complex biological samples.
.svg)
Nutrition and Metabolic Tests Based on metabolomics technology, we provide personalized nutrition and metabolic testing services: strict quality control management and rich clinical information database ensure the accuracy of testing and scientific interpretation of test results.
- Vitamins
- Amino acid profile
- Free fatty acid profile
- Bile acid profile
- Organic acids
- Carnitines
- Polypeptides
- Sugars
Early Screening of Chronic Diseases The first step in getting through the diagnosis and treatment closed-loop is early screening of diseases: comprehensive detection of the changes of chronic disease-related metabolites, early detection and prevention during the development of diseases, and providing reliable scientific evidences for personalized prevention and treatment of diseases.
-
Gut Health Assessment
Research have shown that there is a correlation between gut microbiota and various diseases. By measuring the metabolic differences of related biomarkers, it can provide references for the mechanism research and prognosis evaluation of various chronic diseases and even cancers.
-
Diabetes Mellitus Risk Assessment
The onset of diabetes is often an insidious and gradual process. If the early-stage diabetes progression can be detected before the onset, the individual’s risk level can be identified and comprehensive intervention can be carried out to high-risk groups. It is possible to interrupt or delay the occurrence of diabetes.
-
Cardiovascular Disease Risk Assessment
The incidence of cardiovascular disease is the result of the interaction of many factors, including age, gender, hypertension, hyperlipidemia, diabetes or obesity. In clinical medicine, research on cardiovascular disease risk assessment plays an important role in the prevention and management of cardiovascular diseases.
-
Chronic Liver Disease Risk Assessment
Chronic liver disease refers to the gradual damage and death of liver cells. The liver becomes harder and eventually develops into cirrhosis. When the liver is damaged, liver fibrosis occurs during the repair process. The changes of bile acids combined with other related metabolites in the human body can be used for non-invasive screening of liver fibrosis and cirrhosis, which can be used as auxiliary diagnoses.
Scientific Research Services Driven by the integrated multi-omics of precision medicine : by utilizing multi-omics research technologies, systematically and in depth mining biological information, advancing algorithms, accelerating the research and commercialization of technologies, provide comprehensive support for precision prevention, diagnosis, and treatment.
- Targeted /Non-Targeted Metabolomics Research
- Proteomics Research
- Bioinformatics Data Analysis
